HighTower Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.41M | Buy |
104,934
+4,159
| +4% | +$132K | ﹤0.01% | 1322 |
|
|
2026
Q1 | $2.66M | Buy |
100,775
+1,973
| +2% | +$57.8K | ﹤0.01% | 1549 |
|
|
2025
Q4 | $2.86M | Buy |
98,802
+4,811
| +5% | +$144K | ﹤0.01% | 1490 |
|
|
2025
Q3 | $2.61M | Buy |
93,991
+4,288
| +5% | +$108K | ﹤0.01% | 1487 |
|
|
2025
Q2 | $2.18M | Sell |
89,703
-5,314
| -6% | -$116K | ﹤0.01% | 1519 |
|
|
2025
Q1 | $1.97M | Buy |
95,017
+51,780
| +120% | +$1.3M | ﹤0.01% | 1531 |
|
|
2024
Q4 | $1.02M | Sell |
43,237
-8,472
| -16% | -$208K | ﹤0.01% | 1957 |
|
|
2024
Q3 | $1.32M | Sell |
51,709
-27,859
| -35% | -$709K | ﹤0.01% | 1759 |
|
|
2024
Q2 | $1.87M | Sell |
79,568
-26,057
| -25% | -$658K | ﹤0.01% | 1486 |
|
|
2024
Q1 | $3.03M | Sell |
105,625
-11,814
| -10% | -$355K | ﹤0.01% | 1211 |
|
|
2023
Q4 | $3.85M | Sell |
117,439
-13,904
| -11% | -$378K | 0.01% | 1100 |
|
|
2023
Q3 | $3.65M | Sell |
131,343
-7,975
| -6% | -$261K | 0.01% | 1067 |
|
|
2023
Q2 | $4.76M | Buy |
139,318
+26,535
| +24% | +$834K | 0.01% | 927 |
|
|
2023
Q1 | $3.4M | Buy |
112,783
+12,636
| +13% | +$392K | 0.01% | 1026 |
|
|
2022
Q4 | $2.82M | Sell |
100,147
-41,580
| -29% | -$1.32M | 0.01% | 1093 |
|
|
2022
Q3 | $4.64M | Sell |
141,727
-108,690
| -43% | -$3.99M | 0.01% | 834 |
|
|
2022
Q2 | $7.87M | Buy |
250,417
+38,614
| +18% | +$1.35M | 0.02% | 649 |
|
|
2022
Q1 | $9.72M | Buy |
211,803
+26,966
| +15% | +$1.29M | 0.02% | 639 |
|
|
2021
Q4 | $11.3M | Sell |
184,837
-23,940
| -11% | -$1.66M | 0.02% | 557 |
|
|
2021
Q3 | $15.6M | Buy |
208,777
+442
| +0.2% | +$37.1K | 0.04% | 395 |
|
|
2021
Q2 | $19.3M | Sell |
208,335
-18,359
| -8% | -$1.56M | 0.06% | 322 |
|
|
2021
Q1 | $20.1M | Buy |
226,694
+56,373
| +33% | +$5.59M | 0.06% | 304 |
|
|
2020
Q4 | $15.9M | Buy |
170,321
+53,762
| +46% | +$4.28M | 0.07% | 275 |
|
|
2020
Q3 | $7.42M | Buy |
116,559
+22,634
| +24% | +$1.33M | 0.04% | 427 |
|
|
2020
Q2 | $4.9M | Buy |
93,925
+7,570
| +9% | +$325K | 0.03% | 519 |
|
|
2020
Q1 | $2.7M | Buy |
86,355
+24,001
| +38% | +$802K | 0.02% | 644 |
|
|
2019
Q4 | $2.09M | Buy |
62,354
+2,300
| +4% | +$73.1K | 0.01% | 835 |
|
|
2019
Q3 | $1.78M | Buy |
60,054
+2,103
| +4% | +$68.4K | 0.01% | 927 |
|
|
2019
Q2 | $2M | Buy |
57,951
+6,239
| +12% | +$200K | 0.01% | 902 |
|
|
2019
Q1 | $1.7M | Sell |
51,712
-10,313
| -17% | -$305K | 0.01% | 918 |
|
|
2018
Q4 | $1.49M | Buy |
62,025
+19,921
| +47% | +$561K | 0.01% | 884 |
|
|
2018
Q3 | $1.41M | Buy |
42,104
+12,608
| +43% | +$399K | 0.01% | 980 |
|
|
2018
Q2 | $858K | Buy |
29,496
+9,883
| +50% | +$275K | 0.01% | 1193 |
|
|
2018
Q1 | $507K | Buy |
+19,613
| New | +$531K | ﹤0.01% | 1408 |
|
Other funds holding ARKG
JFG
HighTower Advisors's ARKG Position: Q2 2026 in Review
HighTower Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 4.1% in Q2 2026, buying an estimated $132K and bringing the position to 104,934 shares worth $4.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1322.
HighTower Advisors first reported a position in ARKG in Q1 2018 and has held it in 34 quarters since. The position peaked at $20.1M in Q1 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- HighTower Advisors held 104,934 shares of ARK Genomic Revolution ETF worth $4.41M as of Q2 2026.
- HighTower Advisors bought 4,159 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $132K.
- ARK Genomic Revolution ETF made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1322 holding.
- HighTower Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 34 quarters since.
- HighTower Advisors's ARK Genomic Revolution ETF position peaked at $20.1M in Q1 2021.
- 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.